SYED JAFFER ALI, M.D.
Medical Practice at Columbus St, Cleveland, OH

License number
Ohio 35-037955A
Category
Medical Practice
Type
Specialist
Address
Address
12 Columbus St, Cleveland, OH 44146
Phone
(440) 232-6610
(440) 232-7509 (Fax)

Personal information

See more information about SYED JAFFER ALI at radaris.com
Name
Address
Phone
Syed Ali, age 79
4910 Pondloop Dr, Dublin, OH 43016
(419) 560-2678
Syed Ali
4425 Old English Cir, Bellbrook, OH 45305
(937) 422-6413

Professional information

See more information about SYED JAFFER ALI at trustoria.com
Syed J Ali Photo 1
Dr. Syed J Ali, Bedford OH - MD (Doctor of Medicine)

Dr. Syed J Ali, Bedford OH - MD (Doctor of Medicine)

Specialties:
General Surgery, Vascular Surgery
Address:
Syed J Ali MD
12 Columbus St, Bedford 44146
(440) 232-6610 (Phone)
Procedures:
Aortic Repair, Open or Repair of Arterial Aneurysm, Open
Conditions:
Aortic Aneurysm, Carotid Artery Disease, Cerebral Artery Thrombosis, Cerebral Vascular Disease, Deep Vein Thrombosis (DVT), Venous Embolism and Thrombosis
Languages:
English, Hindi, Telugu, Urdu
Hospitals:
Syed J Ali MD
12 Columbus St, Bedford 44146
UH Regional Hospitals - Bedford
44 Blaine Ave, Bedford 44146
Education:
Medical School
Osmania Medical College, Ntr University Of Health Sciences
Graduated: 1963
Deaconess Hospital
Graduated: 1968
Fairview Hospital
Graduated: 1973
Hillcrest Hospital
Graduated: 1969
St John Hospital
Graduated: 1976


Syed I Ali Photo 2
Syed I Ali, Bedford OH

Syed I Ali, Bedford OH

Specialties:
Radiologist
Address:
12 Columbus St, Bedford, OH 44146
525 E Market St, Akron, OH 44304
Education:
King Edward Medical University - Doctor of Medicine
Bachelor of Medicine, Bachelor of Surgery
The Ottawa Hospital-Civic Campus - Residency - Radiology
Board certifications:
American Board of Radiology Certification in Diagnostic Radiology (Radiology)


Syed Saqib Ali Photo 3
Syed Saqib Ali, Cleveland OH

Syed Saqib Ali, Cleveland OH

Specialties:
Pain Management Specialist
Address:
9500 Euclid Ave, Cleveland, OH 44195
1900 23Rd St, Cuyahoga Falls, OH 44223
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology, American Board of Anesthesiology Sub-certificate in Pain Medicine (Anesthesiology)


Syed Ali Photo 4
Controller At Hanini Oil Company/Marathon Oil Co

Controller At Hanini Oil Company/Marathon Oil Co

Position:
Controller at Hanini Oil Company/Marathon Oil Co
Location:
Cleveland/Akron, Ohio Area
Industry:
Oil & Energy
Work:
Hanini Oil Company/Marathon Oil Co - Controller


Syed S Ali Photo 5
Dr. Syed S Ali, Cleveland OH - MD (Doctor of Medicine)

Dr. Syed S Ali, Cleveland OH - MD (Doctor of Medicine)

Specialties:
Anesthesiology, Pain Medicine Anesthesiology
Age:
45
Address:
9500 Euclid Ave, Cleveland 44195
Center Pain Management
1900 23Rd St, Cuyahoga Falls 44223
(330) 971-7246 (Phone)
Certifications:
Anesthesiology, 2010, Pain Medicine, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
9500 Euclid Ave, Cleveland 44195
Center Pain Management
1900 23Rd St, Cuyahoga Falls 44223
Summa Western Reserve Hospital
1900 23Rd St, Cuyahoga Falls 44223


Syed Ali Photo 6
Alicyclic Imidazoles As H3 Agents

Alicyclic Imidazoles As H3 Agents

US Patent:
6794405, Sep 21, 2004
Filed:
Aug 4, 2003
Appl. No.:
10/344787
Inventors:
Yajing Rong - Beachwood OH
Jack B. Jiang - Orange Village OH
Syed M. Ali - Solon OH
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 314164
US Classification:
514396, 5483451
Abstract:
Alicyclic imidazole compounds; pharmaceutically active compositions containing such compounds; and the use of such compounds in formulations for the control or prevention of disease states in which histamine H receptors are involved, such as allergy, inflammation, hypotension, glaucoma, sleeping disorders, states of hyper- and hypo-motility of the gastro-intestinal tract, cardiovascular disease, hypo- and hyper-activity of the central nervous system, Alzheimers, schizophrenia, obesity and migraines are disclosed.


Syed Ali Photo 7
1H-4(5)-Substituted Imidazole Derivatives

1H-4(5)-Substituted Imidazole Derivatives

US Patent:
6166060, Dec 26, 2000
Filed:
Oct 10, 1997
Appl. No.:
8/948801
Inventors:
James G. Phillips - Bay Village OH
Clark E. Tedford - South Russell OH
Nishith C. Chaturvedi - Gujarat, IN
Syed M. Ali - Solon OH
Assignee:
Gliatech, Inc. - Cleveland OH
International Classification:
A61K 31417, A61K 314174, C07D23364
US Classification:
514400
Abstract:
The present invention provides, in its principal aspect, compounds of the general formula: ##STR1## when A is --NHCO--, --N(CH. sub. 3)--CO--, --NHCH. sub. 2 --, --N(CH. sub. 3)--CH. sub. 2 --, --CH. dbd. CH--, --COCH. sub. 2 --, CH. sub. 2 CH. sub. 2 --, --CH(OH)CH. sub. 2 -- or --C. tbd. C--; X can be H, CH. sub. 3, NH. sub. 2, NH(CH. sub. 3),N(CH. sub. 3). sub. 2, OH, OCH. sub. 3, SH, R. sub. 2 is hydrogen or a methyl or ethyl group; R. sub. 3 is hydrogen or a methyl or ethyl group; n is 0, 1, 2, 3, 4, 5 or 6; R. sub. 1 is selected from the group consisting of (a) alkyl; (b) C. sub. 3 to C. sub. 8 cycloalkyl; (c) phenyl or substituted phenyl; (d) heteroocyclic; and (f) decahydronaphthalene or octahydroindane; and When R. sub. 1 and X taken together denote a 5, 6 or 6, 6 saturated bicyclic ring structure, X can be NH, O, S, SO. sub. 2, When X is constrained in a 5, 6 or 6, 6, saturated bicyclic ring structure, then for example, when X. dbd. NH, R. sub.


Syed Ali Photo 8
Nitrogen-Containing Compounds And Their Use As Glycine Transport Inhibitors

Nitrogen-Containing Compounds And Their Use As Glycine Transport Inhibitors

US Patent:
6946474, Sep 20, 2005
Filed:
Sep 13, 2001
Appl. No.:
10/344962
Inventors:
Syed M. Ali - Solon OH, US
Kurt R. Brunden - Aurora OH, US
Jack B. Jiang - Orange Village OH, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D211/72, C07D211/84, C07D213/72, C07D231/75, C07D231/38
US Classification:
514313, 514353, 514381, 514404, 514535, 514542, 514550, 514562, 514586, 546160, 546305, 548251, 5483684, 5483691, 560 16, 560125, 560426, 562427, 562432, 564 27
Abstract:
The present invention provides trichloroethyl-sulfonylurea-containing compounds that inhibit glycing transporters, pharmaceutical compositions comprising such compounds, methods for using such compounds for inhibiting glycine transporters and methods for using such compounds for the treatment of disease states in which glycine is involved.


Syed Ali Photo 9
Substituted Hydrazine Derivatives

Substituted Hydrazine Derivatives

US Patent:
2002012, Aug 29, 2002
Filed:
Sep 7, 2001
Appl. No.:
09/948848
Inventors:
Syed Ali - Solon OH, US
Kurt Brunden - Aurora OH, US
Dario Doller - Branford CT, US
Brian Herbert - Streetsboro OH, US
Jack Jiang - Orange Village OH, US
Amy Jordan - Parma OH, US
International Classification:
C07D213/88, C07D207/34, C07C311/44, C07C243/22
US Classification:
546/306000, 548/557000, 558/408000, 560/019000, 564/081000, 564/148000, 564/253000, 564/311000
Abstract:
A method for the inhibition of high affinity glycine transporters, compounds that inhibit these transporters; pharmaceutically active compositions comprising such compounds; and the use of such compounds either as above, or in formulations for the control or prevention of disease states in which glycine is involved are disclosed.


Syed Ali Photo 10
Nitrogen-Containing Compounds And Their Use As Glycine Transport Inhibitors

Nitrogen-Containing Compounds And Their Use As Glycine Transport Inhibitors

US Patent:
2002008, Jun 27, 2002
Filed:
Sep 13, 2001
Appl. No.:
09/951170
Inventors:
Syed Ali - Solon OH, US
Kurt Brunden - Aurora OH, US
Jack Jiang - Orange Village OH, US
Assignee:
Gliatech, Inc.
International Classification:
A61K031/47, A61K031/428, A61K031/415, A61K031/41, A61K031/166
US Classification:
514/367000, 514/313000, 514/381000, 514/407000, 514/618000, 546/159000, 548/161000, 548/251000, 548/367400, 564/162000
Abstract:
A method for the inhibition of high affinity glycine transporters, compounds that inhibit these transporters; pharmaceutically active compositions comprising such compounds; and the use of such compounds either as above, or in formulations for the control or prevention of disease states in which glycine is involved are disclosed.